BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1574594)

  • 1. Analysis of cytotoxicity of 131I-labelled OC125 F(ab')2 on human epithelial ovarian cancer cell lines.
    Schneider-Gädicke E; Humm JL; Lau CC; Macklis RM; Bastert G; Knapp RC
    Radiother Oncol; 1992 Mar; 23(3):150-9. PubMed ID: 1574594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
    Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E
    Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of radiolabelled anti-CA125 monoclonal antibody OC125-F(ab)2-fragment following resection guided by antibodies (REGAJ) in ovarian cancer patients.
    Uttenreuther-Fischer MM; Feistel H; Wolf F; Jäger W
    J Clin Lab Anal; 1997; 11(2):94-103. PubMed ID: 9058243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-antigen complex formation following injection of OC125 monoclonal antibody in patients with ovarian cancer.
    Haisma HJ; Battaile A; Stradtman EW; Knapp RC; Zurawski VR
    Int J Cancer; 1987 Dec; 40(6):758-62. PubMed ID: 3480271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and biodistribution of samarium-153-labelled OC125 antibody coupled to CITCDTPA in a xenograft model of ovarian cancer.
    Kraeber-Bodéré F; Mishra A; Thédrez P; Faivre-Chauvet A; Bardiès M; Imai S; Le Boterff J; Chatal JF
    Eur J Nucl Med; 1996 May; 23(5):560-7. PubMed ID: 8698062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human antibody response to the intravenous and intraperitoneal administration of the F(ab')2 fragment of the OC125 murine monoclonal antibody.
    Maher VE; Drukman SJ; Kinders RJ; Hunter RE; Jennings J; Brigham C; Stevens S; Griffin TW
    J Immunother (1991); 1992 Jan; 11(1):56-66. PubMed ID: 1734949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative biodistribution and radioimmunotherapy of monoclonal antibody RS7 and its F(ab')2 in nude mice bearing human tumor xenografts.
    Stein R; Blumenthal R; Sharkey RM; Goldenberg DM
    Cancer; 1994 Feb; 73(3 Suppl):816-23. PubMed ID: 8306265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal radioimmunotherapy of refractory ovarian carcinoma utilizing iodine-131-labeled monoclonal antibody OC125.
    Muto MG; Finkler NJ; Kassis AI; Howes AE; Anderson LL; Lau CC; Zurawski VR; Weadock K; Tumeh SS; Lavin P
    Gynecol Oncol; 1992 Jun; 45(3):265-72. PubMed ID: 1612502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
    Casey JL; Pedley RB; King DJ; Green AJ; Yarranton GT; Begent RH
    Br J Cancer; 1999 Nov; 81(6):972-80. PubMed ID: 10576653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of radiolabelled F(ab')2 fragments of monoclonal antibodies in nude mice bearing intraperitoneally growing human ovarian cancer xenografts.
    Moseley KR; Battaile A; Knapp RC; Haisma HJ
    Int J Cancer; 1988 Sep; 42(3):368-72. PubMed ID: 3417365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy.
    Verel I; Visser GW; Vosjan MJ; Finn R; Boellaard R; van Dongen GA
    Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1645-52. PubMed ID: 15290121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.
    Casey JL; King DJ; Chaplin LC; Haines AM; Pedley RB; Mountain A; Yarranton GT; Begent RH
    Br J Cancer; 1996 Nov; 74(9):1397-405. PubMed ID: 8912535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancer.
    Ychou M; Pelegrin A; Faurous P; Robert B; Saccavini JC; Guerreau D; Rossi JF; Fabbro M; Buchegger F; Mach JP; Artus JC
    Int J Cancer; 1998 Feb; 75(4):615-9. PubMed ID: 9466665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
    Colapinto EV; Zalutsky MR; Archer GE; Noska MA; Friedman HS; Carrel S; Bigner DD
    Cancer Res; 1990 Mar; 50(6):1822-7. PubMed ID: 2407345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daunorubicin conjugated to a monoclonal anti-CA125 antibody selectively kills human ovarian cancer cells.
    Sweet F; Rosik LO; Sommers GM; Collins JL
    Gynecol Oncol; 1989 Sep; 34(3):305-11. PubMed ID: 2788601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution, pharmacokinetics and imaging of 131I-labelled OC125 in ovarian cancer.
    Haisma HJ; Moseley KR; Battaile AI; Griffiths TC; Zurawski VR; Knapp RC
    Int J Cancer Suppl; 1988; 2():109-13. PubMed ID: 3162437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies.
    Lane DM; Eagle KF; Begent RH; Hope-Stone LD; Green AJ; Casey JL; Keep PA; Kelly AM; Ledermann JA; Glaser MG
    Br J Cancer; 1994 Sep; 70(3):521-5. PubMed ID: 8080740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of radiolabeled monoclonal antibody MX35 F(ab')2 in tissue samples by storage phosphor screen image analysis: evaluation of antibody localization to micrometastatic disease in epithelial ovarian cancer.
    Finstad CL; Lloyd KO; Federici MG; Divgi C; Venkatraman E; Barakat RR; Finn RD; Larson SM; Hoskins WJ; Humm JL
    Clin Cancer Res; 1997 Aug; 3(8):1433-42. PubMed ID: 9815829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomas.
    Sharkey RM; Goldenberg DM; Vagg R; Pawlyk D; Wong GY; Siegel JA; Murthy S; Levine GM; Izon D; Gascon P
    Cancer; 1994 Feb; 73(3 Suppl):864-77. PubMed ID: 8306272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical study on human epithelial ovarian carcinoma after radioimmunodetection with 131I-labelled polyclonal antibodies].
    Yang XY
    Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):346-9. PubMed ID: 1782846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.